Encouraging findings for Batten disease drug

The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH. Results from the study were recently published in The Journal of Neuroscience.

Leave A Comment

Your email address will not be published. Required fields are marked *